Skip to content
BlueAlly
Let's talk
Menu
Search BlueAlly

Where do you want to go?

Start typing to narrow the directory.

Strengthening Cybersecurity for a Biotech Company

Risk clarity for a growing genetic medicine company.

Client context

The work begins with the operating reality.

Client

A biotechnology company operating across clinical development, cloud services, laboratories, and core infrastructure.

Engagement

A fast-growing clinical-stage genetic medicine company needed an evidence-based view of risk across a large research and technology environment.

The challenge

What had to change

Rapid growth had expanded the attack surface beyond earlier assessments. Sensitive research, intellectual property, and regulated systems were spread across roughly 2,300 internal IP addresses and 27 external IP addresses.

The client needed current evidence of exploitable weaknesses and a practical remediation order without disrupting the daily work of research and clinical teams.

The BlueAlly solution

How the work came together

BlueAlly performed comprehensive internal and external penetration testing, combining automated discovery with manual validation to confirm real impact and reduce false positives.

Security engineers documented reproducible evidence, assigned risk ratings, and provided specific remediation guidance across access, email, TLS, hosts, services, and network behavior.

The results

What changed

The assessment identified three critical-risk, six high-risk, and six medium-risk vulnerabilities. The client gained a prioritized roadmap for addressing the issues most likely to affect research data, core systems, and compliance posture.

Findings included paths to unauthorized access and email spoofing exposure, allowing the organization to strengthen access controls, harden email policy, and improve audit readiness.

Outcome highlights

What the client gained.

3 critical findings

Focused immediate action on the highest-impact weaknesses.

6 high-risk findings

Created a clear remediation order backed by evidence.

Access protection

Reduced paths to sensitive research data and core services.

Compliance readiness

Connected technical remediation to regulatory resilience.

Related work

More outcomes in Cybersecurity

Simplifying Compliance Management to Strengthen Outcomes

The company achieved and maintained SOC 2 and PCI compliance while improving continuity, operating efficiency, and institutional knowledge.

Read the story

Security by Design Restores Retail PCI Compliance

The retailer passed its PCI audit and established the controls, procedures, and operating practices needed to sustain compliance.

Read the story

Have a similar constraint?

We can start with the current state, the outcome, and the limits around time, risk, and budget.

Talk to an expert